Children of affected individuals are obligate carriers for<unk> . If the CP mutations has been identified in a related individual, prenatal testing is recommended. Siblings of those affected by the disease are at a 25% of<unk> . In asymptomatic siblings, serum concentrations of hemoglobin and hemoglobin A1c should be monitored. To prevent the progression of symptoms of the disease, annual glucose tolerance tests beginning in early teen years to evaluate the onset of diabetes mellitus. Those at risk should avoid taking iron supplements.
Aceruloplasminemia
Hereditary haemochromatosis
Neuroferritinopathy
Sandhoff disease
Familial encephalopathy with neuroserpin inclusion bodies
Hypoplasminogenemia
Paracelsianism
Huntington's disease-like syndrome